Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	117.27	91.3	57.97	55.15	53.19
Other Revenue	-	-	-	0.12	0.15
Revenue	117.27	91.3	57.97	55.26	53.34
Revenue Growth (YoY)	28.44%	57.50%	4.90%	3.61%	-17.54%
Cost of Revenue	49.05	35.84	25.83	22.77	18.95
Gross Profit	68.22	55.47	32.14	32.49	34.39
Selling, General & Admin	77.91	64.29	37.98	34.87	34.49
Research & Development	2.39	1.34	0.92	0.87	0.66
Operating Expenses	80.29	65.63	38.89	35.74	35.14
Operating Income	-12.07	-10.16	-6.76	-3.25	-0.75
Interest Expense	-4.16	-2.94	-1.69	-1	-5.98
Interest & Investment Income	-	0.15	0.03	-	-
Currency Exchange Gain (Loss)	0.01	0.27	-	-	-
Other Non Operating Income (Expenses)	-0.03	-0.05	-	-	-
EBT Excluding Unusual Items	-16.26	-12.73	-8.42	-4.25	-6.73
Legal Settlements	-	-	-	-0.6	-
Other Unusual Items	-	11.69	-	-	-
Pretax Income	-16.26	-1.04	-8.42	-4.85	-6.73
Income Tax Expense	0.19	-1.7	0.07	-	0.3
Net Income	-16.45	0.66	-8.49	-4.85	-7.02
Net Income to Common	-16.45	0.66	-8.49	-4.85	-7.02
Shares Outstanding (Basic)	134	119	94	85	28
Shares Outstanding (Diluted)	134	127	94	85	28
Shares Change (YoY)	5.42%	34.76%	10.10%	199.85%	116.50%
EPS (Basic)	-0.12	0.01	-0.09	-0.06	-0.25
EPS (Diluted)	-0.12	0.01	-0.09	-0.06	-0.25
Free Cash Flow	-16.01	-10.97	-7.11	-1.68	-2.28
Free Cash Flow Per Share	-0.12	-0.09	-0.08	-0.02	-0.08
Gross Margin	58.17%	60.75%	55.44%	58.79%	64.48%
Operating Margin	-10.30%	-11.13%	-11.65%	-5.89%	-1.41%
Profit Margin	-14.03%	0.72%	-14.64%	-8.77%	-13.17%
Free Cash Flow Margin	-13.65%	-12.02%	-12.26%	-3.03%	-4.27%
EBITDA	-7.85	-6.98	-5.46	-1.92	1.33
EBITDA Margin	-6.69%	-7.65%	-9.42%	-3.48%	2.49%
D&A For EBITDA	4.22	3.17	1.29	1.33	2.08
EBIT	-12.07	-10.16	-6.76	-3.25	-0.75
EBIT Margin	-10.30%	-11.13%	-11.65%	-5.89%	-1.41%
Revenue as Reported	117.27	91.3	-	55.26	53.34

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q